Treatment outcomes in triple negative breast cancer patients undergoing neoadjuvant chemotherapy. The importance of Ki-67

被引：0
|
作者：
Rapoport, Bernardo Leon [1 ]
Barnard-Tidy, Jacqui [1 ]
van Eeden, Ronwyn [1 ]
Smit, Teresa [1 ]
Nayler, Simon [2 ]
Benn, Carol [3 ]
机构：
[1] Med Oncol Ctr Rosebank, Johannesburg, South Africa
[2] Gritzman & Thatcher Inc, Johannesburg, South Africa
[3] Netcare Breast Care Ctr, Johannesburg, South Africa
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P2-16-20
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-16-20
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Prognostic factors associated with pathological complete response in early breast cancer patients undergoing neoadjuvant chemotherapy. The importance of Ki-67 and molecular subtype
    Rapoport, B. L.
    Barnard-Tide, J.
    Smit, T.
    Nayler, S.
    Benn, C-A
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [2] Ki-67 as a Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
    Kim, Kwan Il
    Lee, Kyung Hee
    Kim, Tae Ryung
    Chun, Yong Soon
    Lee, Tae Hoon
    Park, Heung Kyu
    [J]. JOURNAL OF BREAST CANCER, 2014, 17 (01) : 40 - 46
  • [3] Ki-67 as predictor of chemotherapy response in neoadjuvant chemotherapy for breast cancer
    Mishra, A. K.
    Kapoor, A.
    Tewari, S.
    Gond, S.
    Kumar, R.
    [J]. BREAST, 2015, 24 : S90 - S90
  • [4] Prognostic function of Ki-67 for pathological complete response rate of neoadjuvant chemotherapy in triple-negative breast cancer
    Zhang, Guojing
    Xie, Wanqing
    Liu, Zhaozhe
    Lin, Chao
    Piao, Ying
    Xu, Long
    Guo, Fang
    Xie, Xiaodong
    [J]. TUMORI JOURNAL, 2014, 100 (02): : 136 - 142
  • [5] Ki-67, p53, and clinical outcomes of patients with triple-negative breast cancer
    Nishiyama, Yasuyuki
    Nishimura, Reiki
    Osako, Tomofumi
    Okumura, Yasuhiro
    Arima, Nobuyuki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [6] Assessment of the Predictive Role of Ki-67 in Breast Cancer Patients Responses to Neoadjuvant Chemotherapy
    Rais, Ghizlane
    Mokfi, Rania
    Boutaggount, Farah
    Maskrout, Meryem
    Bennour, Soundouss
    Senoussi, Chaymae
    Rais, Fadoua
    [J]. EUROPEAN JOURNAL OF BREAST HEALTH, 2024, 20 (03) : 199 - 206
  • [7] Value of Ki-67 in prediction of response to neoadjuvant chemotherapy in breast cancer
    Kim, Kwanil
    Lee, Kyunghee
    Park, Heungkyu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Prognostic factors associated with pathological complete response in early breast cancer patients undergoing neoadjuvant chemotherapy: The importance of Ki-67 and molecular subtype
    Rapoport, B. L.
    Barnard-Tidy, J. A.
    Smit, T.
    Nayler, S. J.
    Benn, C. A.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [9] Change of Ki-67 after long course of neoadjuvant chemotherapy as prognostic factors in patients with stage II, III triple negative breast cancer
    Yang, Yaewon
    Kim, Tae-Yong
    Im, Seock-Ah
    Keam, Bhumsuk
    Lee, Kyung-Hun
    Han, Sae-Won
    Oh, Do-Youn
    Kim, Tae-You
    Moon, Hyeong-Gon
    Han, Wonshik
    Park, In Ae
    Noh, Dong-Young
    [J]. CANCER RESEARCH, 2015, 75
  • [10] Pathological complete response in early breast cancer patients undergoing neoadjuvant chemotherapy: Focus on Ki-67 and molecular subtypes
    Rapoport, B. L.
    Barnard-Tidy, J.
    Van Eeden, R. I.
    Smit, T.
    Nayler, S.
    Benn, C.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 37 - 37
12345